Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry

• Michael J. Kluk,

  Affiliation Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Todd Ashworth,

  Affiliation Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Hongfang Wang,

  Affiliation Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Birgit Knoechel,

  Affiliation Departments of Pediatric Hematology/Oncology and Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

  ⨯
• Emily F. Mason,

  Affiliation Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Elizabeth A. Morgan,

  Affiliation Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• David Dorfman,

  Affiliation Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Geraldine Pinkus,

  Affiliation Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Oliver Weigert,

  Affiliation Departments of Pediatric Hematology/Oncology and Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

  ⨯
• Jason L. Hornick,

  Affiliation Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Lucian R. Chirieac,

  Affiliation Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Michelle Hirsch,

  Affiliation Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• David J. Oh,

  Affiliation Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Andrew P. South,

  Affiliation Division of Cancer Research and Genetics Core Services Unit, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom

  ⨯
• Irene M. Leigh,

  Affiliation Division of Cancer Research and Genetics Core Services Unit, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom

  ⨯
• Celine Pourreyron,

  Affiliation Division of Cancer Research and Genetics Core Services Unit, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom

  ⨯
• Andrew J. Cassidy,

  Affiliation Division of Cancer Research and Genetics Core Services Unit, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom

  ⨯
• Daniel J. DeAngelo,

  Affiliation Departments of Pediatric Hematology/Oncology and Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

  ⨯
• David M. Weinstock,

  Affiliation Departments of Pediatric Hematology/Oncology and Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

  ⨯
• Ian E. Krop,

  Affiliation Departments of Pediatric Hematology/Oncology and Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

  ⨯
• Deborah Dillon,

  Affiliation Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Jane E. Brock,

  Affiliation Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Alexander J. F. Lazar,

  Affiliation Department of Pathology, M. D. Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Myron Peto,

  Affiliation Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, United States of America

  ⨯
• Raymond J. Cho,

  Affiliation Department of Dermatology, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• Alexander Stoeck,

  Affiliation Merck Oncology, Boston, Massachusetts, United States of America

  ⨯
• Brian B. Haines,

  Affiliation Merck Oncology, Boston, Massachusetts, United States of America

  ⨯
• Sriram Sathayanrayanan,

  Affiliation Merck Oncology, Boston, Massachusetts, United States of America

  ⨯
• Scott Rodig,

  Affiliation Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
•  [ ... ],
• Jon C. Aster

  * E-mail: jaster@rics.bwh.harvard.edu

  Affiliation Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• [ view all ]
• [ view less ]